Abiopharma

🔍 Steger Ronald (Executive)

Company: Great Lakes Dredge & Dock CORP (GLDD)

Report Date: 2026-03-31

Detailed Transactions and Holdings:

• Sold 20,404 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: U | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1
• Acquired 1,625 shares of Deferred Stock Units (Derivative)
  Date: 2026-03-31 | Code: A | equity_swap_involved: false | shares_owned_after: 45,068.00 | transaction_form_type: 4 | Footnotes: F2, F2, F2
• Sold 45,068 shares of Deferred Stock Units at $17.0 per share (Derivative)
  Date: 2026-04-01 | Code: D | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F3, F3, F3

Footnotes:

• F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated February 10, 2026, by and among Saltchuk Resources, Inc. ("Parent"), Huron MergeCo, Inc. ("Merger Sub"), and Great Lakes Dredge & Dock Corporation ("Issuer") on April 1, 2026 (the "Effective Time"), Merger Sub merged with and into Issuer, with Issuer surviving as a wholly owned subsidiary of Parent upon consummation of the transactions contemplated by the Merger Agreement. At the Effective Time, each outstanding share of common stock of the Issuer ("Common Stock") was cancelled and converted into the right to receive $17.00 in cash (the "Merger Consideration"), without interest and subject to any required tax withholdings.
• F2: Deferred Stock Units ("DSUs") granted March 31, 2026 and deferred pursuant to the Issuer's Director Deferral Plan.
• F3: Includes 45,068 DSUs. At the Effective Time, each outstanding award of DSUs was canceled and converted into the right to receive an amount in cash equal to the product of the aggregate number of shares of Common Stock underlying such DSU immediately prior to the Effective Time, multiplied by the Merger Consideration.